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In the clinical management of acute ischemic stroke (AIS), endovascular treatment (EVT) has recently been established 
as an effective treatment for patients with a large vessel occlu-
sion.1 Despite the large overall benefits, recent evidence shows 
that specific preprocedural patient characteristics may sub-
stantially influence the prognosis and absolute treatment ben-
efit of the patient after EVT in terms of functional outcome. 
In particular, a larger amount of highly prevalent intracranial 
carotid artery calcification (ICAC) may be an indicator of 
poor functional outcome in AIS patient treated by EVT.2,3 One 
study reported an association between ICAC volume and poor 
recanalization status, which could not be explained by dif-
ferences in procedural difficulties like accessibility of target 
occlusion, number of passes or periprocedural complications.2
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Background and Purpose—Previous studies suggest that intracranial carotid artery calcification (ICAC) volume might 
influence the clinical outcome of patients after endovascular treatment (EVT) for acute ischemic stroke. Importantly, 
ICAC can be subtyped into a medial or intimal pattern that may differentially influence the effect of EVT in patients with 
acute ischemic stroke.
Methods—All 500 patients included in the MR CLEAN (Multicenter Randomized Clinical trial of Endovascular treatment 
for acute ischemic stroke in the Netherlands) were evaluated. Volume (mm3) and location pattern (tunica intima or tunica 
media) of ICAC could be determined on baseline noncontrast computed tomography in 344 patients. Functional outcome 
at 90 days was assessed with the modified Rankin Scale. Next, we investigated the association of ICAC volume and 
pattern with functional outcome using adjusted ordinal logistic regression models. Effect modification by EVT was 
assessed with an interaction term between treatment allocation and ICAC aspect.
Results—We found evidence for treatment effect modification by ICAC pattern (P interaction=0.04). Patients with 
predominantly medial calcification had better functional outcome with EVT than without this treatment (adjusted 
common odds ratio, 2.32; 95% CI, 1.23–4.39), but we observed no effect of EVT in patients with predominantly intimal 
calcifications (adjusted common odds ratio, 0.82; 95% CI, 0.40–1.68). We did not find an association of ICAC volume with 
functional outcome (adjusted common odds ratio per unit increase ICAC volume 1.01 (95% CI, 0.89–1.13). Moreover, 
we found no evidence for effect modification by ICAC volume (P interaction=0.61).
Conclusions—The benefit of EVT in acute ischemic stroke patients with a medial calcification pattern is larger than the 
benefit in patients with an intimal calcification pattern.
Clinical Trial Registration—URL: http://www.trialregister.nl. Unique identifier: NTR1804. URL: http://www.isrctn.com. 
Unique identifier: ISRCTN10888758.   (Stroke. 2018;49:2961-2968. DOI: 10.1161/STROKEAHA.118.022400.)
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Yet, given the retrospective design of previous studies, 
in combination with the older, less effective EVT techniques 
that were investigated, more evidence is required to establish 
whether ICAC influences functional outcome in AIS patients. 
Furthermore, because of the lack of control (non-EVT) groups 
in previous studies modification of treatment effect by ICAC 
volume could not be assessed.
In addition to the volume of ICAC, 2 distinct morpholog-
ical patterns of ICAC were recently highlighted that likely 
represent 2 different pathological processes.4,5 In brief, one 
of the patterns is characterized by calcification in the tunica 
intima (intimal calcification pattern), whereas in the other 
pattern calcification is primarily present in the tunica media 
(medial calcification pattern).6–8 A recently published study 
observed differences in cardiovascular risk factor profile be-
tween patients with intimal and medial calcification patterns.9 
The 2 types of calcification may relate differently to func-
tional outcome and EVT effect in these patients.
Against this background, we performed a post hoc anal-
ysis of the MR CLEAN (Multicenter Randomized Clinical 
trial of Endovascular treatment of Acute ischemic stroke in 
the Netherlands) and investigated the effect of the volume 
and pattern of ICAC on functional outcome and on treatment 
effect.10 This knowledge may directly contribute to our insight 
into factors influencing the success of EVT in AIS patients.
Methods
Anonymized trial data and analytic methods that support our 
study findings are available from the principal investigator (Email 
mrclean@erasmusmc.nl) on reasonable request.
Patients
Data originated from the MR CLEAN trial which investigated the 
effectiveness of EVT in AIS patients.10 All patients had a radiograph-
ically confirmed proximal intracranial arterial occlusion and a min-
imal score of 2 on the National Institutes of Health Stroke Scale at 
baseline. Treatment had to be possible within 6 hours after symptom 
onset. Patients were randomized between EVT (intervention) or no 
EVT (control) along with usual medical care. Intravenous alteplase 
before randomization was allowed. Demographics, laboratory tests, 
and medical cardiovascular history were collected at baseline as pre-
viously described.11 Baseline imaging was performed with noncon-
trast computed tomography (NCCT) and CT angiography (CTA), 
evaluating the Alberta Stroke Program Early CT Score, the location 
of occlusion, and collateral status.12,13 Written informed consent be-
fore randomization was provided by all patients or their legal rep-
resentatives. The study protocol was approved by a central medical 
ethics committee and the research board of each participating center. 
Funders of the original study and this post hoc study had no role in 
study design, data collection, data analysis, data interpretation, or 
writing of the article. All authors had full access to all the data in the 
study and approved the article for publication.
Assessment of ICAC
ICAC Volume
All study participants underwent NCCT before randomization, on 
which ICAC volumes were quantified (mm3) in the symptomatic in-
tracranial internal carotid arteries separately. ICAC was evaluated 
from the horizontal part of the petrous (horizontal) segment of the 
artery till its top (circle of Willis). All segmentations of ICAC volume 
were done manually by 2 experienced observers (K.C.J. Compagne 
and P.R.D. Clephas) with a custom-made, reliable, and validated tool 
in ImageJ.14 The number of pixels with a Hounsfield unit ≥130 was 
multiplied by pixel-size and slice increment to obtain the volume of 
ICAC (mm3). Interobserver agreement has been published previously 
with an intraclass correlation coefficient of 0.99.14
ICAC Pattern
The pattern of ICAC was differentiated into intimal and medial ICAC 
according to a recently developed and validated scoring method15 
(Figure 1). In short, this scoring method evaluates circularity, thick-
ness, and morphology of the calcification using a specific weighting to 
determine whether calcification is predominantly intimal (<7 points) 
or medial (≥7 points). Two observers (K.C.J. Compagne and P.R.D. 
Clephas) independently graded all ICAC calcifications and were 
blinded to the symptomatic side during scoring. In case of disagree-
ment, a consensus reading was performed between both observers.
Outcome Assessment
Functional outcome at 90 days after the intervention was assessed 
with the modified Rankin Scale (mRS) by an independent research 
nurse who was blinded for treatment allocation.16 Recanalization 
status on follow-up CTA at 24 hours, evaluated by the modified ar-
terial occlusive lesion score, was assessed by an independent core 
lab.17 Follow-up infarct volumes at 5 to 7 days follow-up were semi-
automatically segmented on NCCT scans with the use of validated 
software.18 Safety end points were reported by local neurologists. 
Symptomatic intracranial hemorrhage was defined as neurolog-
ical deterioration (an increase of 4 or more points on the National 
Institutes of Health Stroke Scale score) and evidence of intracranial 
hemorrhage on imaging studies.
Population for Analyses
Patients with NCCT scans with a slice thickness >3 mm, that could 
not be assessed reliably for ICAC, were excluded. Other reasons for 
excluding patients were movement artifacts, incomplete scans, in-
appropriate reconstruction, unavailable axial slices, or unavailable 
NCCT scan.
Figure 1. Patterns of medial and intimal in-
tracranial carotid artery calcification on non-
contrast computed tomography (CT). Medial 
calcification pattern is identified as a thin, 
continuous, and almost circular calcification 
patterns in axial viewing plane (A; upper) and 
coronal viewing plane (A; lower). Intimal calci-
fication pattern is identified as a thick, irregular, 
and noncircular calcification patterns in axial 
viewing plane (B; upper) and coronal viewing 
plane (B; lower).
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Statistical Analysis
Baseline characteristics of included patients between both interven-
tion and control group were compared by means of the Mann-Whitney 
U test for continuous variables because of non-normal distributions, 
and χ2 test was used for categorical variables. The correlation be-
tween ICAC volume and age was evaluated by the Spearman rank 
correlation coefficient. Cohen’s kappa value (κ) and proportion of 
agreement were calculated to define the level of interobserver agree-
ment in grading ICAC pattern.
About ICAC volume, data were handled in 2 approaches. First, 
for continuous analyses, ICAC volumes were natural log-transformed 
after adding 1.0 mm3 to all volumes to deal with volumes of 0 mm3 
(ln(ICAC volume +1.0)) because of the skewed distribution. Second, 
quartiles of ICAC volume of the total population were created. For 
illustration purposes, we compared the outcomes between the lower 3 
quartiles with the upper (fourth) quartile; defined as severe ICAC. We 
assessed the association of ICAC volume and pattern (intimal calci-
fication versus medial calcification pattern) with functional outcome 
(mRS score of 0–6) using ordinal logistic regression models (shift 
analysis). Relationships of ICAC volume or pattern with successful 
recanalization on follow-up CTA (modified Arterial Occlusive Lesion 
score) were assessed with adjusted ordinal logistic regression models. 
Linear regression was used to assess to association between ICAC 
volume and pattern with follow-up infarct volume. Modification of 
treatment effect by ICAC volume and pattern was tested with a mul-
tiplicative interaction term. In the first model, adjustments for age 
and sex only were made. In a second model, additional adjustments 
were made for cardiovascular risk factors: smoking, diabetes mel-
litus, atrial fibrillation, myocardial infarction, and history of hyper-
tension according revised Framingham stroke risk profile.19 In the 
third model, adjustments were also made for prestroke mRS, National 
Institutes of Health Stroke Scale at baseline, occlusion of the internal 
carotid artery terminus, collateral status on baseline CTA, and time 
to randomization as proven predictors of outcome.20 P values ≤0.05 
were considered as statistically significant. Analyses were performed 
with R statistical software (version 3.4.2) using packages foreign, 
rms, MASS, irr, and ggplot2.
Results
In total, 128 patients were excluded because of a slice thick-
ness >3 mm on NCCT. Additional reasons for excluding 
patients were movement artifacts (n=20), incomplete scans 
(n=5), inappropriate reconstruction (n=1), unavailable axial 
slices (n=1), and unavailable NCCT scan (n=1). In total, 344 
of the 500 patients (69%) in the MR CLEAN trial were in-
cluded in this post hoc subgroup analysis (Table I in the 
online-only Data Supplement). Baseline characteristics of the 
study participants were equally distributed in the intervention 
and control group as shown in Table 1.
ICAC Volume
ICAC in the symptomatic intracranial carotid artery of is-
chemic stroke (symptomatic ICAC) was present in 270 
(78%) patients: 122/156 (78%) patients in the intervention 
group and 148/188 (79%) patients in the control group. 
Median ICAC volume in the symptomatic carotid artery was 
69.8 mm3 (interquartile range, 19.2–171.1 mm3). A moderate 
correlation (ρ=0.6; P<0.001) between symptomatic ICAC 
volume and age was observed. There was no statistically sig-
nificant difference in median volume of symptomatic ICAC 
between both treatment allocations (respectively, 65.5 versus 
81.9 mm3; P=0.81).
Overall, larger symptomatic ICAC volumes were not 
significantly associated with poorer functional outcome 
Table 1. Baseline Characteristics of Analyzed Patients
 
Control Group 
(n=188)
Intervention 
Group (n=156) P Value
Age, median (IQR) 66 (56–76) 66 (57–76) 0.97
Sex male (%) 108 (57.4) 96 (61.5) 0.51
NIHSS at baseline, median (IQR) 18 (14–22) 18 (14–21) 0.29
Previous stroke (%) 19 (10.1) 22 (14.1) 0.33
Atrial fibrillation (%) 48 (25.5) 44 (28.2) 0.66
Diabetes mellitus (%) 22 (11.7) 26 (16.7) 0.24
Smoking (%) 54 (28.7) 47 (30.1) 0.87
Myocardial infarction (%) 32 (17.0) 23 (14.7) 0.58
Hypertension (%) 89 (47.3) 60 (38.5) 0.12
Prestroke mRS score of ≤2 (%) 171 (91.0) 141 (90.4) 1.00
Systolic blood pressure at 
baseline (mm Hg), median (IQR)
142 (130–160) 143 (128–159) 0.51
Treatment with IV alteplase (%) 170 (90.4) 134 (85.9) 0.26
ASPECTS ≥8 at baseline (%)* 153 (82.3) 116 (74.8) 0.12
Location of intracranial occlusion on baseline CTA (%)§ 0.92
  ICA 3 (1.6) 1 (0.6)  
  ICA-T 48 (25.5) 42 (26.9)  
  M1 116 (61.7) 97 (62.2)  
  M2 19 (10.1) 15 (9.6)  
  A1 or A2 2 (1.1) 1 (0.6)  
Collateral status on baseline CTA (%)† 0.71
  Absent collaterals 11 (6.0) 8 (5.2)  
  Poor collaterals 47 (25.5) 47 (30.3)  
  Moderate collaterals 77 (41.8) 57 (36.8)  
  Good collaterals 49 (26.6) 43 (27.7)  
Extracranial ICA ≥50% 
stenosis (%)
19 (10.1) 212 (13.5) 0.43
Extracranial ICA occlusion (%) 14 (7.4) 11 (7.1) 1.00
No ICAC at symptomatic side of 
stroke (%)
14 (7.4) 11 (7.1) 1.00
ICAC volume at symptomatic 
side of stroke, median (IQR)
41 (1–120) 34 (2–114) 0.81
ICAC pattern at symptomatic side of stroke (%) 0.66
  No calcification 40 (21.3) 34 (21.8)  
  Intimal calcification 61 (32.4) 57 (36.5)  
  Medial calcification 87 (46.3) 65 (41.7)  
Time from stroke onset to 
randomization (min), median 
(IQR)‡
188 (144–260) 191 (147–240) 0.57
ASPECTS indicates Alberta Stroke Program Early CT Score; CTA, computed 
tomography angiography; ICA-T, internal carotid artery terminus; ICAC, intracranial 
carotid artery calcification; IQR, interquartile range; mRS, modified Rankin Scale; 
and NIHSS, National Institutes of Health Stroke Scale.
*ASPECTS was missing for 3 patients.
†Collaterals were graded on baseline CTA on a 4 grade scale: absent 
collaterals (0% filling of occluded territory), poor collaterals (0–49% filling of 
occluded territory), moderate collaterals (50–99% filling of occluded territory), 
and good collaterals (100% filling of occluded territory).
‡Data were missing for 2 patients.
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(adjusted common odds ratio [acOR] per unit increase in log-
transformed ICAC volume 1.01; 95% CI, 0.89–1.13) in our 
first model. After additional adjustments, symptomatic ICAC 
volume was still not significantly associated with functional 
outcome (acOR, 0.99; 95% CI, 0.83–1.03). Treatment effects 
were similar in patients with severe ICAC volume (>119.2 
mm3) and patients with nonsevere ICAC (Table 2) and no 
effect modification was observed (P interaction=0.61). 
Furthermore, the effect of treatment on final recanalization 
status and final infarct volume was comparable in patients 
with severe ICAC volume and patients with nonsevere ICAC 
volume without a significant effect modification (P interac-
tion=0.66 and 0.77, respectively).
ICAC Pattern
In the 270 patients with ICAC, we found 118 intimal calci-
fication patterns and 152 medial calcification patterns in the 
symptomatic intracranial carotid artery (Figure 1). A good 
interobserver agreement was found in grading ICAC pattern 
(total agreement 93.9%; κ=0.88). No difference in distribution 
of ICAC pattern was observed between the intervention and 
control group (P=0.43). Patients with a medial ICAC pattern 
were in general older, more often female and had more often a 
history of diabetes mellitus, myocardial infarction, hyperten-
sion, and poorer collateral status on baseline CTA (Table II in 
the online-only Data Supplement).
In patients with ICAC, a medial calcification pattern was 
not associated with a shift to a poorer functional outcome 
(acOR, 0.62; 95% CI, 0.38–1.04). A significant EVT treat-
ment effect was observed in patients with medial calcifica-
tion pattern (acOR, 2.32; 95% CI, 1.23–4.39). This in contrast 
to patients with intimal calcification pattern, in whom we 
observed no treatment effect (acOR, 0.82; 95% CI, 0.40–
1.68; Table 3; Figure 2). Consequently, a significant effect 
modification by ICAC pattern was noted (P interaction=0.04; 
Table 4). In EVT-treated patients, we observed a lower impact 
of reperfusion on functional outcome in patients with intimal 
ICAC pattern compared with patients with medical ICAC pat-
tern (Table III in the online-only Data Supplement).
Recanalization grades on follow-up CTA were signifi-
cantly higher in the intervention group in patients with medial 
and intimal calcification pattern (respectively, acOR, 11.26; 
95% CI, 3.86–32.90 and acOR, 7.69; 95% CI, 2.41–24.59) 
with no observed significant treatment modification by ICAC 
pattern (P interaction=0.28).
In the control group, median follow-up infarct volumes 
were significantly larger in patients with medial calcifica-
tion pattern compared with intimal calcification pattern (re-
spectively, median volume 99.46 versus 69.52 mL; P=0.01). 
However, in the intervention group, infarct volumes did not 
differ between both calcification patterns (respectively, me-
dian volume 51.93 versus 55.12 mL; P=0.40). Compared with 
patients with intimal calcification pattern, patients with me-
dial calcification pattern showed a larger effect on follow in-
farct volume. However, no significant effect modification was 
observed (P interaction=0.51).
There was no difference in the occurrence of serious 
adverse events or symptomatic intracerebral hemorrhage 
between patients with medial calcification pattern in the treat-
ment and control groups (Table IV in the online-only Data 
Supplement). In patients with intimal calcification pattern, se-
rious adverse events occurred more often in the intervention 
group. However, the absolute difference of 18% between was 
statistically nonsignificant (P=0.07).
Discussion
We did not find an association of ICAC volume with func-
tional outcome after AIS because of large vessel occlusion 
Table 2. Association of Treatment Allocation With Functional Outcome,* Recanalization on CTA and Follow-Up Infarct Volume on CT 
According to Severity of Calcification Volume of the Intracranial Carotid Artery at the Symptomatic Side of Ischemic Stroke
 
Functional Outcome* Recanalization† Follow-Up Infarct Volume‡
acOR (95% CI) acOR (95% CI) β (95% CI)
Intervention vs control group
  Nonsevere ICAC (n=258)
   Model 1 1.64 (1.05 to 2.55) 5.53 (2.99 to 10.28) −0.19 (−0.51 to 0.14)
   Model 2 1.71 (1.09 to 2.69) 5.86 (3.11 to 11.01) −0.21 (−0.53 to 0.12)
   Model 3 1.69 (1.06 to 2.70) 7.91 (3.94 to 15.90) −0.17 (−0.47 to 0.13)
  Severe ICAC (n=86)
   Model 1 1.99 (0.91 to 4.35) 8.83 (2.75 to 28.39) −0.63 (−1.31 to 0.06)
   Model 2 1.67 (0.75 to 3.74) 9.12 (2.54 to 32.76) −0.55 (−1.24 to 0.14)
   Model 3 1.91 (0.80 to 4.57) 6.11(1.54 to 24.27) −0.61 (−1.28 to 0.06)
Model 1: adjusted for age and sex. Model 2: model 1 and plus adjustments for smoking, diabetes mellitus, atrial fibrillation, 
myocardial infarction, and history of hypertension. Model 3: model 2 plus adjustments for prestroke mRs, NIHSS at baseline, 
occlusion of the internal carotid artery terminus, collateral status at baseline CTA, and time to randomization. acOR indicates 
adjusted common odds ratio; CTA, computed tomography angiography; ICAC, intracranial carotid artery calcification; mRS, modified 
Rankin Scale; NCCT, noncontrast computed tomography; and NIHSS, National Institutes of Health Stroke Scale.
*Effect parameters is the acOR for a shift in the direction of a better outcome on the mRS in favor of the intervention.
†Data on recanalization on follow-up CTA was missing for 64 (24%) patients of which 28 patients died.
‡Data on follow-up infarct volume on NCCT 5–7 days was missing for 26 patients (8%) of which 8 patients died before assessment.
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nor modification of EVT treatment effect by ICAC volume. 
We found a trend towards a worse outcome in patients with 
medial ICAC pattern. Notwithstanding, patients with a me-
dial ICAC pattern benefited from EVT in contrast to patients 
with intimal ICAC pattern.
In our analysis, the volume of ICAC was not associated 
with functional outcome as opposed to a recent observa-
tional study.2 This discrepancy may be explained by different 
study design, but selection of patients may have contributed 
to the findings. In that study, EVT was not yet standard care. 
Patients were only eligible for EVT if intravenous thrombol-
ysis was contraindicated and specific clinical characteristics 
(National Institutes of Health Stroke Scale score of ≥6 and 
Alberta Stroke Program Early CT Score of >6) were pre-
sent. Because of the pragmatic design of the randomized MR 
CLEAN trial, the patients included in our study reflect the 
population encountered in clinical practice. Another added 
value of our study compared with previous studies was the 
randomized controlled design which allowed us to inves-
tigate treatment effect modification by ICAC volume and 
pattern.
Two other studies that investigated effect of ICAC on 
revascularization and functional outcome assessed ICAC 
qualitatively using different evaluating approaches which 
did not differentiate between volume or pattern. One study 
included patients with a middle cerebral artery occlusion 
who received EVT and intravenous thrombolysis and found 
a significant association between high calcification burden 
and poor functional outcome (defined as mRS score of 5 
or 6).3 However, the analysis was not stratified by type of 
treatment. Another study included EVT patients by perfu-
sion imaging selection and found no association between 
total carotid siphon calcium score and successful reperfusion 
(Thrombolysis in Cerebral Infarction ≥2b) or good func-
tional outcome (mRS score of ≤2).21 All 3 previous studies 
used a dichotomized mRS as primary outcome, and thus re-
ported only the proportion of patients with a good functional 
outcome. Evaluating the entire mRS range with ordinal 
analysis, allows patients with suboptimal, but clinically im-
portant improvements to be captured and might outperform 
dichotomized outcomes used in other studies.22
In a recently published study, the risk factors of intimal 
and medial calcification patterns in patients with suspected is-
chemic stroke were investigated. Similar results to our obser-
vations were described with regard to clinical characteristics 
across the different ICAC patterns. Patients with medial cal-
cification pattern were significantly older and less often male, 
suffered more often from diabetes mellitus and smoked less 
Table 3. Association of Treatment Allocation With Functional Outcome,* Follow-Up Infarct Volume on CTA and Recanalization 
According to Calcification Pattern
 
Functional Outcome* Recanalization† Follow-Up Infarct Volume‡
acOR (95% CI) acOR (95% CI) β (95% CI)
Intervention vs control group
  Total sample (n=344)
   Model 1 1.70 (1.16 to 2.50) 5.90 (3.44 to 10.12) −0.29 (−0.58 to 0.01)
   Model 2 1.74 (1.18 to 2.56) 6.19 (3.56 to 10.77) −0.31 (−0.61 to −0.02)
   Model 3 1.70 (1.13 to 2.52) 7.47 (4.15 to 13.45) −0.27 (−0.58 to −0.01)
  No calcification (n=74)
   Model 1 2.22 (0.96 to 5.14) 4.42 (1.52 to 12.03) −0.46 (−1.06 to 0.13)
   Model 2 2.27 (0.95 to 5.42) 4.63 (1.59 to 13.49) −0.51 (−1.14 to 0.12)
   Model 3 2.43 (0.99 to 6.05) 5.86 (1.81 to 18.93) −0.45 (−0.96 to 0.06)
  Medial calcification pattern (n=152)
   Model 1 2.63 (1.43 to 4.83) 11.11 (4.11 to 30.06) −0.46 (−0.90 to −0.02)
   Model 2 2.55 (1.38 to 4.72) 12.10 (4.28 to 34.15) −0.41(−0.83 to 0.01)
   Model 3 2.32 (1.23 to 4.39) 11.26 (3.86 to 32.90) −0.28 (−0.69 to 0.13)
Intimal calcification pattern (n=118)
   Model 1 0.81 (0.42 to 1.54) 4.32 (1.76 to 10.60) 0.08 (−0.44 to 0.61)
   Model 2 0.76 (0.39 to 1.50) 3.91 (1.51 to 10.11) 0.13 (−0.41 to 0.68)
   Model 3 0.82 (0.40 to 1.68) 7.69 (2.41 to 24.59) 0.00 (−0.49 to 0.49)
Model 1: adjusted for age and sex. Model 2: model 1 and plus adjustments for smoking, diabetes mellitus, atrial fibrillation, 
myocardial infarction, and history of hypertension. Model 3: model 2 plus adjustments for prestroke mRs, NIHSS at baseline, 
occlusion of the internal carotid artery terminus, collateral status at baseline CTA, and time to randomization. acOR indicates 
adjusted common odds ratio; CTA, computed tomography angiography; ICAC, intracranial carotid artery calcification; mRS, modified 
Rankin Scale; NCCT, noncontrast computed tomography; and NIHSS, National Institutes of Health Stroke Scale.
*Effect parameters is the acOR for a shift in the direction of a better outcome on the mRS in favor of the intervention.
†Data on recanalization on follow-up CTA was missing for 64 (24%) patients of which 28 patients died.
‡Data on follow-up infarct volume on NCCT 5–7 days was missing for 26 patients (8%) of which 8 patients died before assessment.
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often.9 The poor functional outcome in patients with medial 
calcification pattern could be explained by arterial stiffening, 
characterized by an increasing pulse pressure, which causes 
impaired regulation of distal blood flow.23 This may lead to an 
impaired distal microvascular cerebral perfusion and thereby 
failure to improve microvascular function (Windkessel 
effect).24 Earlier studies investigated the pattern of calcifica-
tions in relation to clinical outcome in other cardiovascular 
diseases. They identified medial calcification as a risk factor 
for foot amputation in patients with diabetes mellitus com-
pared with intimal calcifications, and it also appeared to be 
a strong prognostic marker for mortality in dialysis patients 
with end-stage renal disease.25–27
We found a significant treatment effect in favor of EVT in 
patients with medial calcification pattern but not in patients 
with an intimal calcification pattern. One could hypothesize 
Figure 2. Distribution of modified Rankin Scale (mRS) scores at 90 days in patients with no calcification, medial, or intimal calcification pattern of the intracra-
nial carotid artery at symptomatic side of ischemic stroke. A significant difference in the distribution of scores between both groups was observed in patients 
with medial calcification pattern but not in patients with intimal calcification pattern and no calcification. Numbers in bars are absolute numbers.
Table 4. P Interaction Values Between Treatment Groups (Intervention Versus Control) and ICAC Volume or Pattern
 
ICAC Volume ICAC Pattern
Functional 
Outcome Recanalization
Follow-Up Infarct 
Volume
Functional 
Outcome Recanalization
Follow-Up Infarct 
Volume
Model 1 0.428 0.385 0.593 0.009 0.109 0.115
Model 2 0.561 0.391 0.684 0.021 0.126 0.177
Model 3 0.607 0.657 0.770 0.036 0.276 0.511
Model 1: adjusted for age and sex. Model 2: model 1 and plus adjustments for smoking, diabetes mellitus, atrial fibrillation, myocardial 
infarction, and history of hypertension. Model 3: model 2 plus adjustments for prestroke mRS, NIHSS at baseline, occlusion of the internal 
carotid artery terminus, collateral status at baseline CTA, and time to randomization. CTA, computed tomography angiography; ICAC, 
intracranial carotid artery calcification; mRS, modified Rankin Scale; and NIHSS, National Institutes of Health Stroke Scale.
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that patients with medial calcifications, which is accompanied 
by arterial stiffening have already a compromised microcircu-
lation and have developed already a microcollateral pathways. 
Another reason for our findings could be that the thrombus 
is different in patients with intimal and medial calcifications 
and that EVT is less effective in removing the thrombus in 
toto in patients with intimal calcification pattern. Furthermore, 
although infarct volumes in EVT-treated patients did not dif-
fer between the 2 ICAC patterns, the beneficial effect of 
EVT about prevention of infarct volume might be reduced in 
patients with intimal calcification pattern. Intimal calcifica-
tions are associated with local atherosclerotic plaques which 
might lead to plaque disruption and microemboli during stent 
retrieval. Besides, EVT might cause damage to the vascular 
endothelium as has been showed in different studies.28 It is 
known that atherosclerosis is also related to endothelial dam-
age.29–31 It might be possible that endothelium in patients with 
intimal ICAC pattern is more prone to damage which may 
results in secondary injury of brain tissue.
A recent postmortem histopathologic correlation study 
showed that the pattern of ICAC can be reliably assessed on 
NCCT, and the developed scoring method was used in our 
study.15 Since NCCT is daily practice in AIS patients, deter-
mining the pattern of ICAC could be an interesting prognostic 
marker for selection of patients for EVT. Our experience is 
that this scoring method can be easily applied in clinical prac-
tice, as it can be executed quickly, and has a good interob-
server agreement.
There are several limitations to our study. First, the quality 
of NCCT scans varied between patients because of different 
scanning protocols used in the participating centers of the MR 
CLEAN trial. Exclusion of patients in our analysis was slice 
thickness >3 mm which could have led to underestimation 
or overestimation of ICAC volume and misclassification of 
ICAC pattern. Therefore, our post hoc study included a limited 
number of patients, which contributed to the fairly wide CIs. 
Consequently, the results of the current study are rather hy-
pothesis generating than definitive results that merit a change 
in imaging-based selection of AIS patients for EVT. Future 
studies dedicated to this topic must be performed to investi-
gate whether these results hold. Second, significant observed 
baseline characteristics were observed between both ICAC 
patterns which may be important confounders. Although we 
adjusted for these confounding variables using covariable-
adjusted regression analyses. However, residual confound 
might still be present. An important note with regard to these 
baseline differences is that these differences may also partly 
reflect the presence of the dominant ICAC patterns in these 
persons as recently published.9 About the observed differences 
in treatment effect, confounding will be marginal because of 
randomization between EVT and non-EVT. Third, our study 
used the recently published scoring method of Kockelkoren 
et al.15 Another possible scoring method is the modified 
Woodcock scale, which visually characterizes ICAC from 0 
(absent) to 3 (thick, continuous calcification)32,33 combining 
volume and pattern in one score which is not desirable for our 
study. The score by Kockelkoren et al15 is developed to specif-
ically determine the pattern of ICAC and it is histopathologi-
cally validated. Finally, we could not assess impaired cerebral 
microperfusion between both ICAC patterns in our study. In 
the MR CLEAN trial, CT or magnetic resonance imaging per-
fusion scans were not performed by the protocol. For future 
research, it would also be interesting to investigate the asso-
ciation between both degree of white matter hyperintensities 
and both ICAC patterns.
Further studies on patients from larger cohorts and ran-
domized controlled trials are necessary to confirm our 
findings, but also to comprehend the underlying pathophysio-
logical mechanism that determines the relation between ICAC 
pattern, treatment effect, and functional outcome.
Summary
The benefit of EVT in AIS patients with a medial calcification 
pattern is larger than the benefit in patients with an intimal 
calcification pattern.
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